|
AASDH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
8.38396019275933E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
9.727400E-01 |
| Stage1-vs-Stage3 |
3.597400E-01 |
| Stage1-vs-Stage4 |
7.571600E-04 |
| Stage2-vs-Stage3 |
5.289600E-01 |
| Stage2-vs-Stage4 |
2.158100E-02 |
| Stage3-vs-Stage4 |
2.564100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.70150000545055E-08 |
| Normal-vs-Asian |
2.08377759491896E-12 |
| Caucasian-vs-AfricanAmerican |
3.131000E-01 |
| Caucasian-vs-Asian |
7.576200E-01 |
| AfricanAmerican-vs-Asian |
4.961400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.579800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
6.30309999999357E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.772600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.284800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.079000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.643000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.483200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.092000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.069600E-02 |
| Classical-VS-Follicular |
6.659400E-01 |
| Classical-VS-Other |
3.306200E-01 |
| Classical-VS-Normal |
3.88578058618805E-15 |
| Tall-VS-Follicular |
4.006100E-02 |
| Tall-VS-Other |
9.350800E-01 |
| Tall-VS-Normal |
1.6269208202857E-12 |
| Follicular-VS-Other |
4.157000E-01 |
| Follicular-VS-Normal |
5.53701529071304E-12 |
| Other-VS-Normal |
1.93500999999818E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.167700E-02 |
|
|
